ABSTRACT OBJECTIVES This study compared the long-term follow-up results of conservative versus aggressive strategies for provisional side branch (SB) intervention in coronary bifurcation lesions.
ranging from 2% to 30%, depending on the criteria for the SB stenting (3) (4) (5) (6) (7) . In the ran- The design, exclusion and inclusion criteria, and data collection methods of the SMART-STRATEGY trial were previously described (8) . In brief, patients with stable coronary artery disease or non-ST-segment elevation acute coronary syndrome and a de novo coronary bifurcation lesion including an unprotected left main (LM) bifurcation lesion were included. The MV diameter was $2.5 mm, and the SB diameter was $2.3 mm by visual estimation. Patients with hemodynamic instability, left ventricular ejection fraction <25%, and primary PCI were excluded.
Patients were stratified by the presence or absence of an LM bifurcation lesion and were randomized 1:1 to a conservative or aggressive strategy for provisional SB intervention after MV stenting ( Figure 1 ).
For LM bifurcation lesions, the conservative strategy was SB ballooning followed by kissing ballooning for an SB stenosis diameter >75% after MV stenting and SB stenting for an SB stenosis diameter >50% or type B or greater dissection after SB ballooning. The aggressive strategy was SB ballooning followed by kissing ballooning for an SB stenosis diameter >50% after MV stenting and SB stenting for an SB stenosis diameter >30% or type B or greater dissection after SB ballooning. For non-LM bifurcation lesions, the conservative strategy was SB ballooning followed by kissing ballooning for Thrombolysis In Myocardial Infarction flow grade lower than 3 in the SB after MV stenting and SB stenting for Thrombolysis In Myocardial Infarction flow grade lower than 3 in the SB after SB ballooning. The aggressive strategy was SB ballooning followed by kissing ballooning for an SB stenosis diameter >75% after MV stenting and SB stenting for an SB stenosis diameter >50% after SB ballooning. For all cases of SB stenting, the T-stenting and small protrusion technique (9) was used exclusively, and final kissing balloon inflation was mandatory. All procedures were performed under intravascular ultrasound (IVUS) guidance whenever possible (see the Online Appendix for details). The SAS version 9.1 (SAS Institute, Cary, North Carolina) was used for all analyses.
RESULTS

BASELINE CLINICAL AND PROCEDURAL CHARACTERISTICS.
A total of 258 patients with bifurcation lesions were included in the present study. Clinical follow-up data at 3 years were available for all patients: 128 in the conservative group and 130 in the aggressive group. Song et al.
independently associated with lower rates of TVF and TLR at 3-year follow-up (Online Table 3 ). Table 4 ). However, pre-and post-procedural IVUS findings of the MV and SB could not predict the occurrence of TLR after 1 year (Online Table 5 ). The percentages of neointimal area in the proximal MV and distal MV at 9-month follow-up were associated with TLR after 1 year (Figure 4) .
CLINICAL OUTCOMES IN LM AND NON-LM BIFURCATION
LESIONS. Clinical event rates at 3 years in patients receiving the conservative versus aggressive strategy according to LM bifurcation lesion are shown in Table 5 . There was no interaction between treatment strategy and TVF rate across the LM bifurcation lesions (p for interaction ¼ 0.8). In 114 patients (44%) with LM bifurcation lesions, TVF rate was numerically lower in the conservative group than the aggressive group (14.0% vs. 22.8%), but the differences were not significant (HR: 1.69, 95% CI: 0.70 to 4.07). In 144 patients (56%) with non-LM bifurcation lesions, the TVF rate was also insignificantly lower in the conservative group than the aggressive group (9.9% vs. 19.2%, hazard ratio: 2.02, 95% confidence interval: 0.81 to 5.00).
DISCUSSION
We compared different strategies for provisional SB ballooning and stenting in patients undergoing Different strategies for SB intervention resulted in the discrepancies in procedural steps between the 2 groups. Kissing balloon inflation and crossover to a 2-stent technique were implemented less frequently in the conservative group than the aggressive group, which might explain the long-term superiority of the conservative strategy observed in this randomized trial. In the multivariable analysis, the crossover to the 2-stent technique was the most powerful independent predictor of TVF, but kissing balloon Multivariable Cox regression models were adjusted by clinically relevant variables (see Online Tables 3 and 4) .
CI ¼ confidence interval; DES ¼ drug-eluting stent; other abbreviations as in Table 3 . Values are n (%). *Defined as a composite of cardiac death, spontaneous MI, and TVR.
Abbreviations as in Tables 3 and 4 .
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intervention (28, 29) . Third, because the study was an open-label trial, both patients and operators were not blinded to the strategy used, which might have introduced bias in symptom assessment at follow-up.
In addition, routine angiographic follow-up at 9
months may have had a delayed oculostenotic impact on the outcomes. Fourth, many patients were treated with the first-generation DES, which are not used currently. Our findings should be tested in a largescale confirmatory trial using newer generation DES.
Fifth, the provisional approach in coronary bifurcation lesions usually means provisional SB stenting after MV stenting. In this study, our strategies for provisional SB intervention included SB ballooning followed by kissing ballooning after MV stenting.
Finally, T-stenting and a small protrusion technique were exclusively used in all cases of SB stenting.
Thus, extrapolating the findings of this study to other 2-stent techniques might not be appropriate.
CONCLUSIONS
In patients with a large coronary bifurcation lesion WHAT IS NEXT? A large-scale confirmatory study is needed to determine optimal strategies for provisional SB intervention in coronary bifurcation lesions using newer generation DES. Optimal Strategy for Bifurcation Lesions
